Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Patent
1995-06-07
1997-12-16
Killos, Paul J.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
564170, 564352, 562466, 562465, 568808, 568811, 514530, 560 55, C07C 6976, A61K 31557
Patent
active
056987331
ABSTRACT:
Disclosed are 9-deoxyprostaglandins which are useful in the treatment of glaucoma and ocular hypertension. Some of these 9-deoxyprostaglandins are novel. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandins.
REFERENCES:
patent: 4321275 (1982-03-01), Bowler et al.
patent: 5093329 (1992-03-01), Woodward et al.
patent: 5151444 (1992-09-01), Ueno et al.
patent: 5302617 (1994-04-01), Ueno
patent: 5321128 (1994-06-01), Stjernschantz et al.
patent: 5446041 (1995-08-01), Chan et al.
Braun, et al., "Effect of ZK 110.841 on Cerebral Vascular Contraction and TXA.sub.2 --Release Caused by Thrombin-Stimulated Platelets" Archives of Pharmacology 339 Suppl:R37 (1989).
Ney, "Potent Inhibition of FMLP-Induced Neutrophil Activation by the PGD.sub.2 Analogue ZK 110.841" Archives of Pharmacology 339 Suppl:R38 (1989).
"New Research Drug DLO/8149" Drug License Opportunities (IMSWORLD Publications) (Jun. 25, 1990).
Bishop John E.
Dean Thomas R.
Hellberg Mark R.
Selliah Robert D.
Zinke Paul W.
Alcon Laboratories Inc.
Copeland Barry L.
Killos Paul J.
LandOfFree
Use of 9-deoxy prostaglandin derivatives to treat glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 9-deoxy prostaglandin derivatives to treat glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 9-deoxy prostaglandin derivatives to treat glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-208032